1 results match your criteria: "The First Affiliated Hospital of Guangzhou University of TCM. taolili@3126.com[Affiliation]"
Article Synopsis
- The study aimed to evaluate the effectiveness of modified Longdan Xiegan Decoction (LXD) for treating hyperandrogenism in women with polycystic ovary syndrome (POS) categorized as stagnant fire in the Gan channel type.
- Patients were divided into two groups, with one receiving LXD and the other Diane-35, and both treatments were assessed for improvements in menstrual disorders, acne, and hormonal levels over three months.
- Results showed that while both treatments led to significant improvements, the LXD group had a notably lower level of prolactin and reported no adverse reactions, suggesting it could be a safer alternative for these patients.